companydata.dkcompanydata.dk

ROS Therapeutics Holding ApS: Financial statements 2025

CVR: 39507056

Source: annual report 2025, Danish Business Authority

01/01/2025 – 31/12/2025

ROS Therapeutics Holding ApS (CVR 39507056) has filed annual accounts for 2025. In 2025, the company reported a gross profit of DKK -10,750 and a net result of DKK -26,512 compared with DKK -14,342 the year before. Equity in the 2025 report amounted to DKK -116,804.

Gross Profit
DKK -10,750
Profit/Loss
DKK -26,512
Equity
DKK -116,804
Total Assets
DKK 39,877
Employees
0

Development

YearRevenueGross ProfitProfit/LossEquityEmployees
2025--11K-27K-117K0
2024--13K-14K-256K1
2023--13K-14K-243K1
2022--13K-14K-229K1
2021--13K-4.3M-225K1

Official annual report

View the official annual report directly on the page with a Pro subscription.

How creditworthy is ROS Therapeutics Holding ApS?

See the CDS score and get a full credit report with recommended credit limit and payment terms.

Read about the CDS score

Events in 2025

HDJ & LEJ Invest ApS registered as owner of ROS Therapeutics Holding ApSSep 11, 2025

As of September 11, 2025, HDJ & LEJ Invest ApS is registered as an owner of ROS Therapeutics Holding ApS with an ownership share of 90%.

ROS Therapeutics Holding ApS: The 2024 annual report is outJun 19, 2025

ROS Therapeutics Holding ApS has published its annual report for 2024. Gross profit came to DKK -12,875, and the net result was DKK -14,342.

About ROS Therapeutics Holding ApS

ROS Therapeutics Holding ApS is a Danish company of the type Anpartsselskab based in København N, founded in 2018. The company is registered under the industry Ikke-finansielle holdingselskaber. The management consists of Hanne Damgaard Jensen. The company is owned by SPORCON LIFESCIENCE ADVISORS ApS and HDJ & LEJ Invest ApS. According to the 2025 annual report, the company had an average of 0 employees. In 2025, the company reported a gross profit of DKK -10,750 and a net result of DKK -26,512 compared with DKK -14,342 the year before. Equity in the 2025 report amounted to DKK -116,804.

Source: annual report 2025, Danish Business Authority

Other financial years